Getting rid of visual distractors: the why, when, how, and where.


Journal

Current opinion in psychology
ISSN: 2352-2518
Titre abrégé: Curr Opin Psychol
Pays: Netherlands
ID NLM: 101649136

Informations de publication

Date de publication:
10 2019
Historique:
received: 02 11 2018
revised: 01 02 2019
accepted: 08 02 2019
pubmed: 12 3 2019
medline: 4 9 2020
entrez: 12 3 2019
Statut: ppublish

Résumé

Distractor suppression, or the ability to disregard salient distractors while dealing with task-relevant information, is a key component of selective attention. Recent research has shown that distractor suppression can take place in different circumstances and present itself in different guises, which is presumably paralleled by a multiplicity of underlying neural mechanisms. In this review article, we discuss a number of central themes concerning distractor suppression and the underlying neural mechanisms, and also highlight several unresolved issues that will have to be addressed in future investigations.

Identifiants

pubmed: 30856512
pii: S2352-250X(18)30185-4
doi: 10.1016/j.copsyc.2019.02.004
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

135-147

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Leonardo Chelazzi (L)

Department of Neuroscience, Biomedicine and Movement Sciences, University of Verona, Verona, Italy; National Institute of Neuroscience, Verona, Italy. Electronic address: leonardo.chelazzi@univr.it.

Francesco Marini (F)

Swartz Center for Computational Neuroscience, University of California, San Diego La Jolla, CA, USA; Department of Psychology, University of Nevada, Reno, NV, USA.

David Pascucci (D)

Department of Psychology, University of Fribourg, Fribourg, Switzerland.

Massimo Turatto (M)

Center for Mind/Brain Sciences, University of Trento, Trento, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH